MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$58,889K
Net Income
$5,975K
Net Profit Margin
10.15%
EPS
$0.08
Unit: Thousand (K) dollars
Revenue Breakdown
Drug Discovery
Hosted Software
On Premise Software
Others
Revenue Breakdown
software segment-Software Segmen...
drug discovery segment-Drug Disc...
Revenue Breakdown
us-US
emea-EMEA
apac-APAC
non us-Non Us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
58,889
58,587
87,235
54,324
Software Products And Services
9,449
10,863
14,791*
11,111
Drug Discovery
15,794
16,310
15,151*
15,174
Contribution
1,214
1,867
-
-
Total cost of revenues
26,457
29,040
29,942
26,285
Gross profit
32,432
29,547
57,293
28,039
Research and development
40,998
43,824
41,399
42,757
Sales and marketing
10,266
11,603
10,338
9,524
General and administrative (includes related party expense of 165, 109, 330 and 218)
22,715
22,914
22,713
21,705
Total operating expenses
73,979
78,341
74,450
73,986
Loss from operations
-41,547
-48,794
-17,157
-45,947
Gain on equity investments
-
-
0
0
Change in fair value of equity investments
45,868
-13,487
46,999
9,691
Other income
3,026
2,663
3,131
3,623
Total other income
48,894
-10,824
50,130
13,314
Income (gain) before income taxes
7,347
-59,618
32,973
-32,633
Income taxes (benefit) at statutory federal rate
-
-
-5,372*
-
State and local taxes, net of federal income tax effect
-
-
-12*
-
Foreign tax effects, other foreign
-
-
-98*
-
Other
-
-
38*
-
General business credits
-
-
3,186*
-
Changes in valuation allowance
-
-
7,931*
-
Equity compensation
-
-
589*
-
Section 162 officer's compensation
-
-
318*
-
Other
-
-
136*
-
Changes in unrecognized tax benefits
-
-
1,248*
-
Transfer pricing
-
-
-864*
-
Other, net
-
-
-265*
-
Income tax expense
1,372
408
462
162
Net income (gain)
5,975
-60,026
32,511
-32,795
Basic EPS
0.08
-0.81
0.441
-0.45
Diluted EPS
0.08
-0.81
0.441
-0.45
Basic Average Shares
74,712,581
73,989,137
73,674,551
73,613,090
Diluted Average Shares
75,769,360
73,989,137
73,674,551
73,613,090
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
Hosted Software
$15,150K
On Premise
Software
$9,297K
Maintenance
$4,878K
Professional Services
$3,219K
Change in fair value of
equity investments
$45,868K
(901.70%↑ Y/Y)
Other income
$3,026K
(-44.35%↓ Y/Y)
Software Products And
Services
$32,544K
(149.78%↑ Y/Y)
Drug Discovery
$22,986K
(47.61%↑ Y/Y)
Contribution
$3,359K
Total other income
$48,894K
(388.11%↑ Y/Y)
Total revenues
$58,889K
(7.54%↑ Y/Y)
Income (gain) before
income taxes
$7,347K
(117.13%↑ Y/Y)
Loss from operations
-$41,547K
(21.47%↑ Y/Y)
Gross profit
$32,432K
(23.99%↑ Y/Y)
Total cost of revenues
$26,457K
(-7.50%↓ Y/Y)
Net income (gain)
$5,975K
(113.84%↑ Y/Y)
Income tax expense
$1,372K
(378.05%↑ Y/Y)
Total operating
expenses
$73,979K
(-6.43%↓ Y/Y)
Drug Discovery
$15,794K
(1.43%↑ Y/Y)
Software Products And
Services
$9,449K
(-27.48%↓ Y/Y)
Contribution
$1,214K
Research and development
$40,998K
(-4.96%↓ Y/Y)
General and
administrative (includes...
$22,715K
(-9.82%↓ Y/Y)
Sales and marketing
$10,266K
(-4.36%↓ Y/Y)
Buy us a coffee
Schrodinger, Inc. (SDGR)
Schrodinger, Inc. (SDGR)